The AUC of the risk score was 0.795 in predicting the overall survival of BC patients, which was superior to that of clinicopathological variables, including age, M stage, N stage, T stage, stage, menopausal status, ER expression, HER2 expression, and PR expression (Fig. 4C). The gene discussed is ERBB2; the disease is breast cancer.